{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/REVBW/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REVBW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REVBW\",,,,,undefined,":{"symbol":"REVBW","market":"US","secType":"STK","nameCN":"Revelation Biosciences, Inc.","latestPrice":0.0108,"timestamp":1743433501617,"preClose":0.01,"halted":0,"volume":1162,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":0.0008,"latestTime":"03-31 12:42:39 EDT","open":0.0108,"high":0.0108,"low":0.0108,"amount":12.5496,"amplitude":0,"askPrice":0.0125,"askSize":1000,"bidPrice":0.0093,"bidSize":100,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1743451200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.01,"postHourTrading":{"tag":"盘后","latestPrice":0.0118,"preClose":0.0118,"latestTime":"17:33 EDT","volume":3000,"amount":35.3,"timestamp":1743197582992},"volumeRatio":0.213773},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REVBW\",,,,,undefined,":{"symbol":"REVBW","floatShares":0,"roa":"-52.93%","roe":"-264.85%","lyrEps":0,"volumeRatio":0.213773,"shares":0,"dividePrice":0,"high":0.0108,"amplitude":0,"preClose":0.01,"low":0.0108,"week52Low":0.004,"pbRate":"0.00","week52High":0.0413,"institutionHeld":0,"latestPrice":0.0108,"committee":-0.818182,"eps":0,"divideRate":0,"volume":1162,"delay":0,"ttmEps":0,"open":0.0108,"prevYearClose":0.007,"prevWeekClose":0.0118,"prevMonthClose":0.0171,"prevQuarterClose":0.007,"fiveDayClose":0.0145,"twentyDayClose":0.017,"sixtyDayClose":0.007},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REVBW\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2469465791","title":"Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10","url":"https://stock-news.laohu8.com/highlight/detail?id=2469465791","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469465791?lang=en_us&edition=fundamental","pubTime":"2024-09-24 18:00","pubTimestamp":1727172000,"startTime":"0","endTime":"0","summary":"Figure 1. Upregulation of IL-10 at 2 Hours Post Intravenous Administration of Gemini . Using high sensitivity serum IL-10 biomarker analysis to gain further insight into Gemini’s capability for resolution of inflammation, Revelation tested samples from the Phase 1 clinical study. It was found that Gemini induced statistically significant, dose dependent changes in circulatory IL-10 at 2 hours post-dose, with a p-value of < 0.05 or greater, at each of the low, mid, and high dose levels, as shown in Figure 1. The change in IL-10 observed for treatment groups relative to placebo, were a 27-fold increase, 162-fold increase, and 309-fold increase for the low, mid, and high dose groups, respectively.IL-10 is a potent anti-inflammatory protein that downregulates pro-inflammatory cytokines and is an active contributor to initiating reduction of inflammation. The significant increase of anti-inflammatory IL-10 with no significant increase in pro-inflammatory IL-1β and TNF-α confirms TLR4 bindin","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9gwYA.AvUG5Zr1xjhKAy0w--~B/aD0yNDk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/41c031265fa5b95275ce11e29c213040","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9gwYA.AvUG5Zr1xjhKAy0w--~B/aD0yNDk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/41c031265fa5b95275ce11e29c213040"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/revelation-biosciences-gemini-induces-dose-100000890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["REVB","REVBW","BK4139"],"gpt_icon":0}],"pageSize":16,"totalPage":2,"pageCount":2,"totalSize":17}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REVBW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REVBW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REVBW\",market:\"US\",delay:false,,,undefined,":{}}}